HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marshall Posner Selected Research

Squamous Cell Neoplasms (Squamous Cell Cancer)

10/2018Therapeutic Immune Modulation against Solid Cancers with Intratumoral Poly-ICLC: A Pilot Trial.
4/2004Adjusting for patient selection suggests the addition of docetaxel to 5-fluorouracil-cisplatin induction therapy may offer survival benefit in squamous cell cancer of the head and neck.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marshall Posner Research Topics

Disease

18Neoplasms (Cancer)
04/2021 - 06/2002
18Squamous Cell Carcinoma of Head and Neck
01/2021 - 06/2002
13Head and Neck Neoplasms (Head and Neck Cancer)
01/2016 - 01/2004
8Oropharyngeal Neoplasms
10/2019 - 07/2014
4Mucositis
01/2019 - 12/2003
4Carcinoma (Carcinomatosis)
08/2016 - 10/2003
2Inflammation (Inflammations)
10/2018 - 01/2014
2Squamous Cell Neoplasms (Squamous Cell Cancer)
10/2018 - 04/2004
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
06/2015 - 01/2012
2Febrile Neutropenia
09/2014 - 03/2013
2Xerostomia
10/2009 - 07/2007
2Infections
11/2004 - 04/2004
1Fatigue
10/2018
1Melanoma (Melanoma, Malignant)
10/2018
1Overweight
01/2018
1Hyperuricemia
01/2017
1Fever (Fevers)
01/2017
1Thrombocytopenia (Thrombopenia)
01/2017
1Sepsis (Septicemia)
01/2017
1Extranodal Extension
01/2016
1Weight Loss (Weight Reduction)
01/2016
1Margins of Excision
01/2016
1Disease Progression
06/2015
1Neutropenia
09/2014
1Marijuana Use
01/2014
1Carcinogenesis
01/2014
1Tongue Neoplasms (Tongue Neoplasm)
01/2014
1Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
07/2013
1Second Primary Neoplasms (Neoplasms, Second)
01/2013
1Adenoid Cystic Carcinoma (Cylindroma)
01/2013
1Residual Neoplasm
11/2010
1Stomatitis
10/2009
1Nasopharyngeal Carcinoma
03/2009
1Epstein-Barr Virus Infections
03/2009
1Neoplasm Metastasis (Metastasis)
06/2008
1Pathologic Complete Response
06/2006

Drug/Important Bio-Agent (IBA)

8Docetaxel (Taxotere)FDA Link
01/2019 - 01/2003
6Fluorouracil (Carac)FDA LinkGeneric
01/2017 - 01/2003
6Cisplatin (Platino)FDA LinkGeneric
09/2014 - 01/2003
4AntibodiesIBA
10/2017 - 04/2004
4Carboplatin (JM8)FDA LinkGeneric
09/2014 - 03/2003
4Paclitaxel (Taxol)FDA LinkGeneric
05/2014 - 03/2003
3Biomarkers (Surrogate Marker)IBA
10/2019 - 06/2015
3AntigensIBA
11/2018 - 07/2015
3Biological ProductsIBA
08/2015 - 11/2013
3CytokinesIBA
01/2014 - 03/2009
2RNA (Ribonucleic Acid)IBA
04/2021 - 10/2018
2DNA (Deoxyribonucleic Acid)IBA
01/2021 - 01/2004
2EpitopesIBA
11/2018 - 11/2004
2ChemokinesIBA
10/2018 - 01/2014
2Amifostine (Ethyol)FDA LinkGeneric
10/2009 - 12/2003
2Trastuzumab (Herceptin)FDA Link
02/2004 - 10/2003
1Viral AntigensIBA
04/2021
1AfatinibIBA
01/2019
1Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
11/2018
1Tumor Viral Antigens (Large T Antigen)IBA
11/2018
1poly ICLCIBA
10/2018
1Double-Stranded RNA (RNA, Double Stranded)IBA
10/2018
1Poly I-CIBA
10/2018
1Carboxymethylcellulose Sodium (Polycell)FDA Link
10/2018
1Lysine (L-Lysine)FDA Link
10/2018
1LigandsIBA
10/2018
1Immunoglobulin G (IgG)IBA
10/2017
1cabazitaxelFDA Link
01/2017
1PlatinumIBA
01/2017
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2016
1GemcitabineFDA Link
09/2014
14- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA
09/2014
1Antineoplastic Agents (Antineoplastics)IBA
05/2014
1Taxoids (Taxanes)IBA
05/2014
1CannabinoidsIBA
01/2014
1Anticarcinogenic AgentsIBA
01/2014
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2014
1Panitumumab (Vectibix)FDA Link
11/2013
1vandetanib (ZD6474)IBA
08/2013
1Membrane Proteins (Integral Membrane Proteins)IBA
07/2013
1liposomal doxorubicin (Doxil)FDA Link
01/2012
1Growth Factor ReceptorsIBA
11/2010
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2009
1InterleukinsIBA
10/2009
1Neoplasm Antigens (Tumor Antigens)IBA
03/2009
1Peptides (Polypeptides)IBA
03/2009
1cevimeline (Evoxac)FDA Link
07/2007
1ErbB Receptors (EGF Receptor)IBA
09/2006
1Cetuximab (Erbitux)FDA Link
09/2006
1mannuronic acidIBA
11/2004

Therapy/Procedure

12Therapeutics
01/2021 - 04/2004
12Radiotherapy
01/2019 - 09/2006
7Induction Chemotherapy
06/2014 - 01/2003
7Chemoradiotherapy
06/2014 - 12/2003
3Drug Therapy (Chemotherapy)
08/2008 - 04/2004
2Immunotherapy
11/2018 - 11/2010
2Enteral Nutrition (Feeding, Tube)
01/2018 - 12/2003
2Aftercare (After-Treatment)
01/2017 - 07/2014
2Adjuvant Chemoradiotherapy
08/2016 - 01/2016
2Combined Modality Therapy
06/2008 - 08/2007
1Gastrostomy
01/2016
1Tonsillectomy
07/2015
1Molecular Targeted Therapy
11/2010
1Oral Administration
07/2007